New CFO appointed; API business to move into new wholly owned subsidiary

Management Changes View source PDF Explain this filing

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.5%Reaction day

₹2371.00

prior close

₹2377.60

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%-1.9% vs market

Pharmaceuticals peers, median of 159sector-0.4%-2.1% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 2.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.2

15m

-0.4

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.5-0.6-1.9-0.4-2.1

Next day

-1.3-1.5+0.2-1.3-0.0

-2.4-1.8-0.5-1.3-1.1

-1.3-0.6-0.7-0.4-0.9

-1.4+0.8-2.2+0.1-1.5

-0.6+0.8-1.4+0.3-0.8

-0.1-0.2+0.2-0.7+0.6

15d

-0.9+1.1-1.9+0.9-1.7

-2.4-3.5+1.1-2.6+0.1

-17.0-3.2-13.8-4.1-13.0

-18.9-12.8-6.1-10.8-8.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board appointed Mr. Amol Lone, a chartered accountant with over 20 years of finance experience, as the new Chief Financial Officer effective December 15, 2025. It also approved setting up a new wholly owned subsidiary, RPG Active Pharma Limited, and transferring its active pharmaceutical ingredients (API) business to it as a going concern for about Rs 50 crore. The API business contributed Rs 90.24 crore or about 13.8 percent of FY25 turnover. The company plans to invest up to Rs 105 crore in the new unit in one or more tranches.

Likely market impact

Restructuring is internal at book value, broadly neutral for shareholders. New CFO brings two decades of finance experience.